Literature DB >> 15164168

Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells.

N M Al-Rasheed1, F Meakin, E L Royal, A J Lewington, J Brown, G B Willars, N J Brunskill.   

Abstract

AIMS/HYPOTHESIS: Proinsulin C-peptide is generally believed to be inert without any appreciable biological functions. However, it has been shown to modulate a variety of cellular processes important in the pathophysiology of diabetic complications. We therefore investigated the ability of C-peptide to stimulate intracellular signalling pathways in kidney proximal tubular cells, the altered activation of which may possibly be related to the development of diabetic nephropathy.
METHODS: Extracellular signal-regulated kinase (ERK) and Akt phosphorylation were evaluated by western blotting. ERK activity was measured by in vitro kinase assay. Intracellular Ca(2+) was evaluated by confocal imaging. The membrane and cytosol-associated fractions of protein kinase C (PKC) isoforms were evaluated by western blotting. Proliferation was assessed by thymidine incorporation assay.
RESULTS: Using the opossum proximal tubular kidney cell line as a model, we demonstrated that at high picomolar to low nanomolar concentrations, C-peptide stimulates extracellular signal-regulated mitogen-activated kinase (3.3+/-0.1-fold over basal at 3 minutes) and phosphatidylinositol 3-kinase (4.1+/-0.05-fold over basal at 5 minutes). ERK activation was attenuated by pre-treatment with a PKC inhibitor and abolished by pertussis toxin. Elevations of intracellular [Ca(2+)] are seen in response to 5 nmol/l C-peptide with consequent activation of PKC-alpha. Pre-treatment with pertussis toxin abolished PKC-alpha. C-peptide is also a functional mitogen in this cell type, stimulating significantly increased cell proliferation. Proliferation was attenuated by wortmannin and pertussis toxin pre-treatments. None of these effects is reproduced by scrambled C-peptide. CONCLUSIONS/
INTERPRETATION: This study provides evidence that C-peptide, within physiological concentration ranges, stimulates many signalling pathways in opossum kidney cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15164168     DOI: 10.1007/s00125-004-1404-9

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  49 in total

1.  Lysophosphatidic acid-induced proliferation in opossum kidney proximal tubular cells: role of PI 3-kinase and ERK.

Authors:  R J Dixon; N J Brunskill
Journal:  Kidney Int       Date:  1999-12       Impact factor: 10.612

Review 2.  Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury.

Authors:  A O Phillips; R Steadman
Journal:  Histol Histopathol       Date:  2002-01       Impact factor: 2.303

3.  Prevention of vascular and neural dysfunction in diabetic rats by C-peptide.

Authors:  Y Ido; A Vindigni; K Chang; L Stramm; R Chance; W F Heath; R D DiMarchi; E Di Cera; J R Williamson
Journal:  Science       Date:  1997-07-25       Impact factor: 47.728

4.  Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits.

Authors:  P Crespo; N Xu; W F Simonds; J S Gutkind
Journal:  Nature       Date:  1994-06-02       Impact factor: 49.962

Review 5.  Proinsulin and C-peptide: a review.

Authors:  A E Kitabchi
Journal:  Metabolism       Date:  1977-05       Impact factor: 8.694

6.  C-peptide binding to human cell membranes: importance of Glu27.

Authors:  A Pramanik; K Ekberg; Z Zhong; J Shafqat; M Henriksson; O Jansson; A Tibell; M Tally; J Wahren; H Jörnvall; R Rigler; J Johansson
Journal:  Biochem Biophys Res Commun       Date:  2001-06-01       Impact factor: 3.575

7.  C-peptide improves autonomic nerve function in IDDM patients.

Authors:  B L Johansson; K Borg; E Fernqvist-Forbes; T Odergren; S Remahl; J Wahren
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

Review 8.  The extracellular matrix in diabetic nephropathy.

Authors:  F N Ziyadeh
Journal:  Am J Kidney Dis       Date:  1993-11       Impact factor: 8.860

9.  Role of enhanced arachidonate availability through phospholipase A2 pathway in mediation of increased prostaglandin synthesis by glomeruli from diabetic rats.

Authors:  P A Craven; M C Patterson; F R DeRubertis
Journal:  Diabetes       Date:  1988-04       Impact factor: 9.461

10.  C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism.

Authors:  Bo-Lennart Johansson; John Wahren; John Pernow
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-06-10       Impact factor: 4.310

View more
  15 in total

1.  C-peptide is a bioactive peptide.

Authors:  J Wahren; K Ekberg; H Jörnvall
Journal:  Diabetologia       Date:  2007-01-18       Impact factor: 10.122

2.  C-peptide ameliorates kidney injury following hemorrhagic shock.

Authors:  Ranjit S Chima; Giuseppe Maltese; Timberly Lamontagne; Giovanna Piraino; Alvin Denenberg; Michael O'Connor; Basilia Zingarelli
Journal:  Shock       Date:  2011-05       Impact factor: 3.454

Review 3.  C-Peptide and its career from innocent bystander to active player in diabetic atherogenesis.

Authors:  Corinna Lebherz; Nikolaus Marx
Journal:  Curr Atheroscler Rep       Date:  2013-07       Impact factor: 5.113

4.  Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein.

Authors:  R S Mughal; J L Scragg; P Lister; P Warburton; K Riches; D J O'Regan; S G Ball; N A Turner; K E Porter
Journal:  Diabetologia       Date:  2010-05-12       Impact factor: 10.122

Review 5.  An update on the potential role of C-peptide in diabetes and osteoporosis.

Authors:  Arturo Pujia; Carmine Gazzaruso; Tiziana Montalcini
Journal:  Endocrine       Date:  2017-04-03       Impact factor: 3.633

6.  Proinsulin C-peptide antagonizes the profibrotic effects of TGF-beta1 via up-regulation of retinoic acid and HGF-related signaling pathways.

Authors:  Claire E Hills; Gary B Willars; Nigel J Brunskill
Journal:  Mol Endocrinol       Date:  2010-03-02

7.  C-peptide stimulates ERK1/2 and JNK MAP kinases via activation of protein kinase C in human renal tubular cells.

Authors:  Z Zhong; A Davidescu; I Ehrén; K Ekberg; H Jörnvall; J Wahren; A V Chibalin
Journal:  Diabetologia       Date:  2004-12-29       Impact factor: 10.122

8.  C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy.

Authors:  Claire E Hills; Nawal Al-Rasheed; Nouf Al-Rasheed; Gary B Willars; Nigel J Brunskill
Journal:  Am J Physiol Renal Physiol       Date:  2008-12-17

Review 9.  Physiological effects and therapeutic potential of proinsulin C-peptide.

Authors:  Gina L C Yosten; Christine Maric-Bilkan; Patrizia Luppi; John Wahren
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-09-23       Impact factor: 4.310

10.  Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorption.

Authors:  Lina Nordquist; Russell Brown; Angelica Fasching; Patrik Persson; Fredrik Palm
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.